Judging from the numbers reported by the nation’s top U.S. clusters, 2020 saw record-high amounts of lab space and NIH funding, as well as record-high numbers of jobs and patents. Those highs are reflected in high regional numbers seen in GEN’s annual ranking of the nation’s top 10 biopharma clusters. The pandemic reshuffled the bottom of GEN’s regional rankings but not the top, for now.